Collectively, we identified a significantly increased CD14 + CD163 high-monocyte subtype in AIDP patients, which highly expressed IL1R2, and a decreased CD14 + CD163 low-monocyte subtype in AIDP patients which highly expressed IL1β. This evidence concerns the gene CD163 and Guillain-Barre syndrome, familial.